SST and colorectal carcinoma: Another experimental CRC model (HT-29, HCT-15, and HCT-116 cells) demonstrated the effect of a targeted cytotoxic SST analogue, AN-162, consisting of doxorubicin (DOX) conjugated to the SST carrier RC-121.